You are here

Article info

Article menu

Download PDFPDF

Review
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?

Authors

  • Hongbin Wang Department of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, California, USACollege of Graduate Studies, California Northstate University, Elk Grove, California, USA PubMed articlesGoogle scholar articles
  • Mia Borlongan College of Graduate Studies, California Northstate University, Elk Grove, California, USA PubMed articlesGoogle scholar articles
  • Howard L Kaufman Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USAAnkyra Therapeutics, Inc, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Uyen Le Department of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, California, USA PubMed articlesGoogle scholar articles
  • Hans J Nauwynck Laboratory of Virology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium PubMed articlesGoogle scholar articles
  • Samuel D Rabkin Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Dipongkor Saha Department of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, California, USA PubMed articlesGoogle scholar articles

Citation

Wang H, Borlongan M, Kaufman HL, et al
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?
Journal for ImmunoTherapy of Cancer 2024;12:e008025. doi: 10.1136/jitc-2023-008025
Online issue publication 
May 31, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.